What standards apply to an MDB for pharmaceutical facilities?

The primary design standard is IEC 61439-2 for low-voltage switchgear and controlgear assemblies, supported by IEC 61439-1 for general requirements. Individual devices inside the MDB are typically compliant with IEC 60947, such as ACBs, MCCBs, contactors, and motor protection devices. If the assembly interfaces with hazardous solvent areas, IEC 60079 may be relevant. For arc-fault considerations, IEC TR 61641 is often used as a design reference. Pharmaceutical projects may also require documentation, FAT/SAT, and validation evidence aligned with GMP expectations and the plant’s quality system.

What enclosure features are recommended for pharmaceutical MDB panels?

Pharmaceutical MDBs usually need smooth, cleanable surfaces, corrosion-resistant construction, and protection against dust and moisture ingress. Common choices include powder-coated steel or stainless steel enclosures with IP31, IP42, or higher ratings depending on room conditions. Anti-condensation heaters, filtered ventilation, and carefully sealed cable entries help maintain performance. In cleanroom-adjacent installations, the panel layout should minimize dust traps and support wipe-down cleaning. For critical utility rooms, temperature management and component spacing are also important to keep internal temperature rise within the limits defined by IEC 61439.

What short-circuit rating should a pharmaceutical MDB have?

The short-circuit withstand rating depends on the transformer capacity, upstream utility fault level, and downstream selectivity requirements. In pharmaceutical plants, common design values include 25 kA, 36 kA, 50 kA, 65 kA, and in larger facilities up to 100 kA for 1 second or 3 seconds, as defined and verified under IEC 61439. The incomer ACB and busbar system must be coordinated with outgoing MCCBs and protective relays to ensure fault clearing without unnecessary outage. Final values should be validated by short-circuit studies and manufacturer-tested assembly designs.

Should an MDB for pharmaceuticals include harmonic mitigation?

Yes, harmonic mitigation is often recommended because pharmaceutical plants use many nonlinear loads, including VFDs, UPS systems, rectifiers, and switch-mode power supplies. Harmonics can overheat transformers and neutral conductors, distort voltage, and interfere with sensitive instrumentation. Typical mitigation methods include line reactors, passive harmonic filters, active harmonic filters, and 12-pulse or 18-pulse drive arrangements where justified. Power quality monitoring within the MDB helps track THDv, THDi, and power factor so the facility can maintain stable operation and protect process equipment.

What forms of separation are suitable for an MDB in a GMP facility?

Forms of separation are selected based on maintenance philosophy, safety, and uptime requirements. In pharmaceutical plants, Form 3b or Form 4 are common because they separate busbars, functional units, and outgoing terminals to improve personnel safety and allow maintenance on individual feeders. Form 4b offers the highest degree of separation and is useful where production continuity is critical. The selected form must be verified in the IEC 61439 assembly design and matched with the internal layout, cable routing, and accessibility requirements of the facility.

Can PLC and SCADA systems be integrated with a pharmaceutical MDB?

Yes. Modern pharmaceutical MDBs often include power meters, multifunction relays, and communication gateways for integration with PLC, SCADA, BMS, and energy management platforms. Common protocols include Modbus TCP, Profibus, Profinet, and Ethernet/IP. Integration enables remote breaker status, trip alarms, energy trending, and load shedding logic for noncritical loads. For critical utilities, the control architecture should be designed with proper segregation between power and automation wiring, EMC protection, and validated alarm handling to support operational reliability and GMP traceability.

What components are typically included in a pharmaceutical MDB?

A pharmaceutical MDB commonly includes an incomer ACB, outgoing MCCBs, metering devices, surge protection devices, control power supplies, and busbar systems rated for the plant load. Depending on the application, it may also feed MCCs, VFDs, soft starters, capacitor banks for APFC, and protection relays for feeder coordination. Critical utility panels often include selector switches, indication lamps, communication modules, and load monitoring. Component selection should follow IEC 60947 ratings and be coordinated to meet the assembly’s thermal, dielectric, and short-circuit performance under IEC 61439.

How is an MDB validated for pharmaceutical use?

Validation typically combines design verification, factory acceptance testing, and site acceptance testing. Under IEC 61439, the assembly must be verified for temperature rise, dielectric properties, short-circuit withstand, clearances, creepage distances, and mechanical operation. Pharmaceutical projects often add project-specific FAT/SAT procedures, documentation packages, wiring schedules, test certificates, and traceability records for critical devices. If the MDB supports GMP areas, the deliverables may also include commissioning checklists, calibration certificates for meters, and integration tests for alarm and communication functions.

Industry + Panel

Main Distribution Board (MDB) for Pharmaceuticals

Main Distribution Board (MDB) design considerations and requirements for Pharmaceuticals applications, addressing industry-specific compliance standards.

Overview

Main Distribution Board (MDB) assemblies for pharmaceutical facilities must support highly controlled, safety-critical power distribution while maintaining compliance with stringent hygiene, uptime, and validation requirements. Typical designs are based on IEC 61439-2 for LV switchgear assemblies, with coordination to IEC 61439-1 for general rules, IEC 60947 for devices such as ACBs, MCCBs, contactors, motor protection circuit breakers, and IEC 60364 for installation practices. In regulated environments, the MDB often feeds process skids, HVAC systems, cleanroom air handling units, purified water systems, compressors, and packaging lines, so reliability and selective discrimination are essential. A pharmaceutical MDB may incorporate air circuit breakers up to 6300 A or more as incomers, molded-case circuit breakers for outgoing feeders, and metering packages for energy monitoring, power quality, and load profiling. Where process equipment includes motors and variable torque loads, feeders may supply VFDs, soft starters, and motor control centers, with attention to harmonic mitigation using passive filters, line reactors, or active harmonic filters. Automatic power factor correction, surge protective devices, and redundant control power supplies are also common to maintain operational continuity and protect sensitive PLC, SCADA, and DCS systems. Environmental design is critical. Panels are frequently specified with IP31, IP42, or higher ingress protection depending on room classification, with corrosion-resistant enclosures, stainless steel or powder-coated mild steel construction, anti-condensation heaters, filtered ventilation, and controlled internal temperature rise. In cleanroom-adjacent areas, the assembly should minimize dust retention, avoid exposed sharp edges, and support easy wipe-down cleaning. For hazardous solvent-handling zones or API production areas, additional assessment against IEC 60079 may be needed if the MDB interfaces with classified locations. Where there is a concern about arc event resilience, IEC TR 61641 guidance may be applied for internal arc-fault behavior, especially for large incoming sections and busbar compartments. Form of separation is selected based on maintainability and safety needs; Form 3b or Form 4 arrangements are common in critical plants to isolate outgoing feeders and allow maintenance without full shutdown. Busbar ratings are typically engineered for 800 A to 5000 A or higher, with short-circuit withstand ratings of 25 kA, 36 kA, 50 kA, 65 kA, or even 100 kA depending on transformer size and utility fault level. For GMP-compliant pharmaceutical operations, the MDB must also support documentation, traceability, and FAT/SAT verification aligned with the validation lifecycle. Critical alarm contacts, Modbus TCP, Profibus, Profinet, or Ethernet/IP gateways may be integrated for BMS and energy management systems. The result is a robust, maintainable, and standards-based Main Distribution Board that supports production continuity, regulatory compliance, and safe expansion for future process lines and utility loads.

Key Features

Main Distribution Board (MDB) configured for Pharmaceuticals requirements
Industry-specific environmental ratings and protections
Compliance with sector-specific standards and regulations
Optimized component selection for industry applications
Integration with industry-standard control and monitoring systems

Specifications

Panel Type	Main Distribution Board (MDB)
Industry	Pharmaceuticals
Base Standard	IEC 61439-2
Environment	Industry-specific ratings

Back to Hubs

Pharmaceuticals

Main Distribution Board (MDB)

Frequently Asked Questions

Need a Custom Panel Built to Spec?

Patrion's engineering team designs and manufactures IEC 61439 compliant panels. Get a design review or quote.

Contact Patrion Call +90 232 332 22 78